Smyrna, GA, United States of America

Benay Sager

This inventor holds 1 USPTO granted patent. Top assignee: Novartis Ag. Active years: 2010.


Average Co-Inventor Count = 4.0

ph-index = 1

Forward Citations = 24(Granted Patents)


Company Filing History:


Years Active: 2010

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Benay Sager: Innovator in Ophthalmic Device Technology

Introduction

Benay Sager is a prominent inventor based in Smyrna, GA (US). She has made significant contributions to the field of ophthalmic devices, particularly in the production of contact lenses. Her innovative approach utilizes advanced techniques to enhance the quality and customization of these essential vision aids.

Latest Patents

Benay Sager holds a patent for a "Method for making ophthalmic devices." This invention provides a novel method for the production of contact lenses through stereolithography. The technique involves the polymerization and solidification of a contact lens forming liquid material by actinic irradiation, layer by layer. This method allows for the creation of contact lenses tailored to the specific prescriptions of individual patients.

Career Highlights

Sager's career is marked by her work at Novartis AG, a leading global healthcare company. Her role in the development of ophthalmic devices has positioned her as a key player in the industry. With her innovative patent, she has contributed to advancements that improve patient outcomes and enhance the functionality of contact lenses.

Collaborations

Benay has collaborated with notable colleagues, including Rafael Victor Andino and Robert Scott Meece. These partnerships have fostered a creative environment that encourages the exchange of ideas and the development of cutting-edge technologies in the field of ophthalmology.

Conclusion

Benay Sager's contributions to ophthalmic device technology exemplify her dedication to innovation and patient care. Her patented methods for producing customized contact lenses represent a significant advancement in the industry. Through her work at Novartis AG and collaborations with esteemed colleagues, she continues to shape the future of vision correction.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to [email protected]
Loading…